Skip to main content
. Author manuscript; available in PMC: 2016 Nov 10.
Published in final edited form as: J Control Release. 2015 Sep 1;217:170–182. doi: 10.1016/j.jconrel.2015.08.048

Figure 7.

Figure 7

In vivo tumor growth inhibition in two subcutaneous xenograft tumor models. Nonradioactive 175Lu was loaded into LCP NPs to act as a vehicle control. One dose per mouse was delivered intravenously on Day 0 (arrows). A) Human UMUC3 bladder cancer supplemented with murine 3T3 fibroblasts. B) Human H460 non-small cell lung cancer. Initial tumor sizes ~100–150 mm3; n = 5–8; †p<0.03, ‡p<5e-5, *p<0.015.